BioCube, Inc.
BICB · OTC
1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2013 | |
|---|---|---|---|---|
| Market Cap | $648 | $1,809 | $293 | $241 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $847 |
| Enterprise Value | $649 | $1,809 | $293 | $1,088 |
| Revenue | $0 | – | – | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | – | – | $0 |
| % Margin | – | – | – | – |
| EBITDA | $189 | – | – | -$90 |
| % Margin | – | – | – | – |
| Net Income | -$39 | – | – | -$764 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | – | – | -0.025 |
| % Growth | – | – | – | – |
| Operating Cash Flow | -$24 | – | – | -$61 |
| Capital Expenditures | $0 | – | – | $0 |
| Free Cash Flow | -$24 | – | – | -$61 |